273 related articles for article (PubMed ID: 27381005)
1. 4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6.
Jayabal S; Chang HH; Cullen KE; Watt AJ
Sci Rep; 2016 Jul; 6():29489. PubMed ID: 27381005
[TBL] [Abstract][Full Text] [Related]
2. Transient cerebellar alterations during development prior to obvious motor phenotype in a mouse model of spinocerebellar ataxia type 6.
Jayabal S; Ljungberg L; Watt AJ
J Physiol; 2017 Feb; 595(3):949-966. PubMed ID: 27531396
[TBL] [Abstract][Full Text] [Related]
3. Rapid Onset of Motor Deficits in a Mouse Model of Spinocerebellar Ataxia Type 6 Precedes Late Cerebellar Degeneration.
Jayabal S; Ljungberg L; Erwes T; Cormier A; Quilez S; El Jaouhari S; Watt AJ
eNeuro; 2015; 2(6):. PubMed ID: 26730403
[TBL] [Abstract][Full Text] [Related]
4. Loss of Flocculus Purkinje Cell Firing Precision Leads to Impaired Gaze Stabilization in a Mouse Model of Spinocerebellar Ataxia Type 6 (SCA6).
Chang HHV; Cook AA; Watt AJ; Cullen KE
Cells; 2022 Sep; 11(17):. PubMed ID: 36078147
[TBL] [Abstract][Full Text] [Related]
5. Ataxic phenotype with altered Ca
Hashiguchi S; Doi H; Kunii M; Nakamura Y; Shimuta M; Suzuki E; Koyano S; Okubo M; Kishida H; Shiina M; Ogata K; Hirashima F; Inoue Y; Kubota S; Hayashi N; Nakamura H; Takahashi K; Katsumoto A; Tada M; Tanaka K; Sasaoka T; Miyatake S; Miyake N; Saitsu H; Sato N; Ozaki K; Ohta K; Yokota T; Mizusawa H; Mitsui J; Ishiura H; Yoshimura J; Morishita S; Tsuji S; Takeuchi H; Ishikawa K; Matsumoto N; Ishikawa T; Tanaka F
Neurobiol Dis; 2019 Oct; 130():104516. PubMed ID: 31229688
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological Studies Support Utility of Positive Modulators of SK Channels for the Treatment of Spinocerebellar Ataxia Type 2.
Egorova PA; Bezprozvanny IB
Cerebellum; 2022 Oct; 21(5):742-749. PubMed ID: 34978024
[TBL] [Abstract][Full Text] [Related]
7. Human Olfactory Ensheathing Cell Transplantation Improves Motor Function in a Mouse Model of Type 3 Spinocerebellar Ataxia.
Hsieh J; Liu JW; Harn HJ; Hsueh KW; Rajamani K; Deng YC; Chia CM; Shyu WC; Lin SZ; Chiou TW
Cell Transplant; 2017 Oct; 26(10):1611-1621. PubMed ID: 29251109
[TBL] [Abstract][Full Text] [Related]
8. In vivo analysis of the spontaneous firing of cerebellar Purkinje cells in awake transgenic mice that model spinocerebellar ataxia type 2.
Egorova PA; Gavrilova AV; Bezprozvanny IB
Cell Calcium; 2021 Jan; 93():102319. PubMed ID: 33248384
[TBL] [Abstract][Full Text] [Related]
9. Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2.
Dell'Orco JM; Pulst SM; Shakkottai VG
Hum Mol Genet; 2017 Oct; 26(20):3935-3945. PubMed ID: 29016852
[TBL] [Abstract][Full Text] [Related]
10. Spinocerebellar ataxia type 6 protein aggregates cause deficits in motor learning and cerebellar plasticity.
Mark MD; Krause M; Boele HJ; Kruse W; Pollok S; Kuner T; Dalkara D; Koekkoek S; De Zeeuw CI; Herlitze S
J Neurosci; 2015 Jun; 35(23):8882-95. PubMed ID: 26063920
[TBL] [Abstract][Full Text] [Related]
11. Altered synaptic and firing properties of cerebellar Purkinje cells in a mouse model of ARSACS.
Ady V; Toscano-Márquez B; Nath M; Chang PK; Hui J; Cook A; Charron F; Larivière R; Brais B; McKinney RA; Watt AJ
J Physiol; 2018 Sep; 596(17):4253-4267. PubMed ID: 29928778
[TBL] [Abstract][Full Text] [Related]
12. Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype.
Kaemmerer WF; Rodrigues CM; Steer CJ; Low WC
Neuroscience; 2001; 103(3):713-24. PubMed ID: 11274790
[TBL] [Abstract][Full Text] [Related]
13. Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum.
Takahashi M; Ishikawa K; Sato N; Obayashi M; Niimi Y; Ishiguro T; Yamada M; Toyoshima Y; Takahashi H; Kato T; Takao M; Murayama S; Mori O; Eishi Y; Mizusawa H
Neuropathology; 2012 Dec; 32(6):595-603. PubMed ID: 22393909
[TBL] [Abstract][Full Text] [Related]
14. Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels.
Watase K; Barrett CF; Miyazaki T; Ishiguro T; Ishikawa K; Hu Y; Unno T; Sun Y; Kasai S; Watanabe M; Gomez CM; Mizusawa H; Tsien RW; Zoghbi HY
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11987-92. PubMed ID: 18687887
[TBL] [Abstract][Full Text] [Related]
15. Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model.
Aikawa T; Mogushi K; Iijima-Tsutsui K; Ishikawa K; Sakurai M; Tanaka H; Mizusawa H; Watase K
Hum Mol Genet; 2015 Sep; 24(17):4780-91. PubMed ID: 26034136
[TBL] [Abstract][Full Text] [Related]
16. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron.
Miyazaki Y; Du X; Muramatsu S; Gomez CM
Sci Transl Med; 2016 Jul; 8(347):347ra94. PubMed ID: 27412786
[TBL] [Abstract][Full Text] [Related]
17. The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
Tsunemi T; Ishikawa K; Tsukui K; Sumi T; Kitamura K; Mizusawa H
J Neurol Sci; 2010 May; 292(1-2):81-4. PubMed ID: 20181362
[TBL] [Abstract][Full Text] [Related]
18. Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6.
Cook AA; Jayabal S; Sheng J; Fields E; Leung TCS; Quilez S; McNicholas E; Lau L; Huang S; Watt AJ
Sci Adv; 2022 Sep; 8(37):eabh3260. PubMed ID: 36112675
[TBL] [Abstract][Full Text] [Related]
19. Endosomal dysfunction contributes to cerebellar deficits in spinocerebellar ataxia type 6.
Cook AA; Leung TCS; Rice M; Nachman M; Zadigue-Dube É; Watt AJ
Elife; 2023 Dec; 12():. PubMed ID: 38084749
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1.
Notartomaso S; Zappulla C; Biagioni F; Cannella M; Bucci D; Mascio G; Scarselli P; Fazio F; Weisz F; Lionetto L; Simmaco M; Gradini R; Battaglia G; Signore M; Puliti A; Nicoletti F
Mol Brain; 2013 Nov; 6():48. PubMed ID: 24252411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
